Walbert Keli
Spruce Biosciences, Inc. · Director
Walbert Keli is listed in public filings as director. This Walbert Keli insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spruce Biosciences, Inc. (SPRB), and Apellis Pharmaceuticals, Inc. (APLS). Investors use Walbert Keli's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $90k1.7k shares | Grant / ExerciseMay 21, 2026 | $89.6K1.7k shares | $52.70 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $015.4k shares | OtherMay 14, 2026 | $507.8K15.4k shares | $33.00 | -- | |
| $014.7k shares | OtherMay 14, 2026 | $368.9K14.7k shares | $25.12 | -- | |
| $017.1k shares | OtherMay 14, 2026 | $217.1k shares | $0.0001 | -- | |
| --7.3k shares | OtherMay 14, 2026 | Disclosure amount unavailable7.3k shares | -- | -- | |
| $369k14.7k shares | Grant / ExerciseJan 1, 2026 | $368.9K14.7k shares | $25.12 | -- | |
| --17.1k shares | Grant / ExerciseJan 1, 2026 | Disclosure amount unavailable8k shares | -- | -- | |
| $301k3.4k shares | Grant / ExerciseDec 11, 2025 | $300.6K3.4k shares | $88.41 | -- |